Natraj Proteins Ltd to Approve Q3 and Nine Months Results on Feb 13, 2026

Natraj Proteins Ltd has announced that its Board of Directors will meet on February 13, 2026, to consider and approve the Standalone Un-Audited Financial Results for the quarter and nine months ended 31st December, 2025. The meeting will also consider the Limited Review Report by the Statutory Auditors for the same period. The trading window for dealing in the company’s securities is closed and will open 48 hours after the financial results are declared to the Stock Exchanges.